Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avidan U Neumann

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|April 10, 2020
Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposureMehmet Gökkaya, Athanasios Damialis, Thomas Nussbaumer, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Journal of Hepatology|August 6, 2005
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis CStefan Zeuzem, Jean-Michel Pawlotsky, Esther Lukasiewicz, et al.
The British Journal of Dermatology|January 16, 2026
Associations between early-life exposures and the infant skin microbiomeConor Broderick, Casper Sahl Poulsen, Mathis Hjort Hjelmsø, et al.
Gastroenterology|October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.
Allergy|September 13, 2019
Pollen exposure weakens innate defense against respiratory virusesStefanie Gilles, Cornelia Blume, Maria Wimmer, et al.
Nature Communications|March 30, 2026
Early life bacteria and sibling exposure associate with restoration of the infant gut microbiome after cesarean sectionJie Jiang, Casper Sahl Poulsen, Ulrika Boulund, et al.
Experimental Dermatology|August 13, 2021
The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseasesHarri Alenius, Hanna Sinkko, Lucas Moitinho-Silva, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|April 10, 2020
Defining biomarkers to predict symptoms in subjects with and without allergy under natural pollen exposureMehmet Gökkaya, Athanasios Damialis, Thomas Nussbaumer, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Journal of Hepatology|August 6, 2005
International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis CStefan Zeuzem, Jean-Michel Pawlotsky, Esther Lukasiewicz, et al.
The British Journal of Dermatology|January 16, 2026
Associations between early-life exposures and the infant skin microbiomeConor Broderick, Casper Sahl Poulsen, Mathis Hjort Hjelmsø, et al.
Gastroenterology|October 9, 2007
HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)Massimo Pilli, Alessandro Zerbini, Amalia Penna, et al.
Journal of the American Academy of Dermatology|January 22, 2018
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman-Yassky, Patrick M Brunner, Avidan U Neumann, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.
Allergy|September 13, 2019
Pollen exposure weakens innate defense against respiratory virusesStefanie Gilles, Cornelia Blume, Maria Wimmer, et al.
Nature Communications|March 30, 2026
Early life bacteria and sibling exposure associate with restoration of the infant gut microbiome after cesarean sectionJie Jiang, Casper Sahl Poulsen, Ulrika Boulund, et al.
Experimental Dermatology|August 13, 2021
The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseasesHarri Alenius, Hanna Sinkko, Lucas Moitinho-Silva, et al.
Pageof 9